Does Caudal Block Increase the Incidence of Urethrocutaneous Fistula Formation Following Hypospadias Repair in Infants?

NCT02861950 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2024-07-01

No results posted yet for this study

Summary

This is a prospective randomized multi-center non-inferiority trial conducted through the Pediatric Regional Anesthesia Network study sites to determine if caudal block increases the incidence of urethrocutaneous fistula following distal or mid shaft hypospadias repair compared with penile nerve block.

Conditions

  • Hypospadias
  • Urethrocutaneous Fistula

Interventions

DRUG

Caudal block with ropivacaine

Patients in this arm will receive a caudal block with ropivacaine

DRUG

penile nerve block with bupivacaine

Patients in this arm will receive a penile block with bupivacaine

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER
  • Dartmouth-Hitchcock Medical Center

    collaborator OTHER
  • Boston Children's Hospital

    collaborator OTHER
  • Children's Medical Center of Dallas/UT Southwestern

    collaborator UNKNOWN
  • University of Mississippi Medical Center

    collaborator OTHER
  • University of New Mexico

    collaborator OTHER
  • University of Michigan

    collaborator OTHER
  • Children's National Research Institute

    collaborator OTHER
  • University of Wisconsin, Madison

    collaborator OTHER
  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Megan Brockel, MD · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Months
Max Age
2 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-24
Primary Completion
2023-09-20
Completion
2023-09-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02861950 on ClinicalTrials.gov